nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ALB—liver cancer	0.213	1	CbGaD
Pitavastatin—UGT2B7—Epirubicin—liver cancer	0.156	0.33	CbGbCtD
Pitavastatin—ABCC2—Sorafenib—liver cancer	0.0716	0.152	CbGbCtD
Pitavastatin—ABCG2—Sorafenib—liver cancer	0.0648	0.138	CbGbCtD
Pitavastatin—SLC10A1—bile canaliculus—liver cancer	0.0516	0.358	CbGeAlD
Pitavastatin—ABCC2—Doxorubicin—liver cancer	0.0435	0.0923	CbGbCtD
Pitavastatin—ABCG2—Doxorubicin—liver cancer	0.0393	0.0835	CbGbCtD
Pitavastatin—CYP2C8—Sorafenib—liver cancer	0.0345	0.0733	CbGbCtD
Pitavastatin—ABCC2—bile canaliculus—liver cancer	0.0259	0.18	CbGeAlD
Pitavastatin—CYP2C9—Sorafenib—liver cancer	0.0241	0.0511	CbGbCtD
Pitavastatin—ABCB1—Sorafenib—liver cancer	0.0233	0.0496	CbGbCtD
Pitavastatin—SLC10A1—bile duct—liver cancer	0.0161	0.112	CbGeAlD
Pitavastatin—ABCB1—Doxorubicin—liver cancer	0.0142	0.0301	CbGbCtD
Pitavastatin—SLC10A1—bile—liver cancer	0.0124	0.0858	CbGeAlD
Pitavastatin—ABCC2—bile duct—liver cancer	0.0081	0.0561	CbGeAlD
Pitavastatin—ORM1—bile—liver cancer	0.00758	0.0525	CbGeAlD
Pitavastatin—ABCC2—bile—liver cancer	0.00623	0.0431	CbGeAlD
Pitavastatin—Atorvastatin—AHR—liver cancer	0.00285	0.625	CrCbGaD
Pitavastatin—HMGCR—gall bladder—liver cancer	0.00238	0.0165	CbGeAlD
Pitavastatin—ORM1—gall bladder—liver cancer	0.0021	0.0146	CbGeAlD
Pitavastatin—ALB—gall bladder—liver cancer	0.00184	0.0128	CbGeAlD
Pitavastatin—UGT1A3—liver—liver cancer	0.00164	0.0114	CbGeAlD
Pitavastatin—Interstitial lung disease—Sorafenib—liver cancer	0.00151	0.0603	CcSEcCtD
Pitavastatin—Rhabdomyolysis—Sorafenib—liver cancer	0.00121	0.0482	CcSEcCtD
Pitavastatin—SLCO1B3—liver—liver cancer	0.00116	0.00801	CbGeAlD
Pitavastatin—Fluvastatin—CYP1A1—liver cancer	0.00101	0.222	CrCbGaD
Pitavastatin—SLC10A1—liver—liver cancer	0.00101	0.00698	CbGeAlD
Pitavastatin—UGT2B7—liver—liver cancer	0.000945	0.00655	CbGeAlD
Pitavastatin—Hepatic failure—Sorafenib—liver cancer	0.000864	0.0345	CcSEcCtD
Pitavastatin—Renal failure acute—Sorafenib—liver cancer	0.000841	0.0336	CcSEcCtD
Pitavastatin—Myositis—Epirubicin—liver cancer	0.000806	0.0322	CcSEcCtD
Pitavastatin—Pain in extremity—Sorafenib—liver cancer	0.000777	0.031	CcSEcCtD
Pitavastatin—Myositis—Doxorubicin—liver cancer	0.000746	0.0298	CcSEcCtD
Pitavastatin—Rosuvastatin—ALB—liver cancer	0.000699	0.153	CrCbGaD
Pitavastatin—HMGCR—liver—liver cancer	0.000698	0.00483	CbGeAlD
Pitavastatin—Nasopharyngitis—Sorafenib—liver cancer	0.000694	0.0277	CcSEcCtD
Pitavastatin—SLCO1B1—liver—liver cancer	0.000668	0.00463	CbGeAlD
Pitavastatin—Abdominal discomfort—Sorafenib—liver cancer	0.000643	0.0257	CcSEcCtD
Pitavastatin—Erectile dysfunction—Sorafenib—liver cancer	0.000618	0.0247	CcSEcCtD
Pitavastatin—ORM1—liver—liver cancer	0.000617	0.00427	CbGeAlD
Pitavastatin—SLCO2B1—liver—liver cancer	0.000591	0.0041	CbGeAlD
Pitavastatin—Jaundice—Sorafenib—liver cancer	0.000583	0.0233	CcSEcCtD
Pitavastatin—ALB—liver—liver cancer	0.000541	0.00375	CbGeAlD
Pitavastatin—ABCC2—liver—liver cancer	0.000507	0.00351	CbGeAlD
Pitavastatin—Muscle spasms—Sorafenib—liver cancer	0.00045	0.0179	CcSEcCtD
Pitavastatin—Myalgia—Sorafenib—liver cancer	0.000398	0.0159	CcSEcCtD
Pitavastatin—Arthralgia—Sorafenib—liver cancer	0.000398	0.0159	CcSEcCtD
Pitavastatin—ABCB1—embryo—liver cancer	0.000394	0.00273	CbGeAlD
Pitavastatin—CYP2C8—liver—liver cancer	0.00038	0.00263	CbGeAlD
Pitavastatin—ABCG2—liver—liver cancer	0.00037	0.00256	CbGeAlD
Pitavastatin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000348	0.0139	CcSEcCtD
Pitavastatin—CYP2C9—liver—liver cancer	0.000338	0.00234	CbGeAlD
Pitavastatin—Dyspepsia—Sorafenib—liver cancer	0.000336	0.0134	CcSEcCtD
Pitavastatin—Fatigue—Sorafenib—liver cancer	0.000329	0.0131	CcSEcCtD
Pitavastatin—Constipation—Sorafenib—liver cancer	0.000326	0.013	CcSEcCtD
Pitavastatin—Hepatic failure—Epirubicin—liver cancer	0.000319	0.0127	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Sorafenib—liver cancer	0.000312	0.0124	CcSEcCtD
Pitavastatin—Renal failure acute—Epirubicin—liver cancer	0.000311	0.0124	CcSEcCtD
Pitavastatin—Urticaria—Sorafenib—liver cancer	0.000303	0.0121	CcSEcCtD
Pitavastatin—Abdominal pain—Sorafenib—liver cancer	0.000302	0.012	CcSEcCtD
Pitavastatin—Hepatic failure—Doxorubicin—liver cancer	0.000295	0.0118	CcSEcCtD
Pitavastatin—Renal failure acute—Doxorubicin—liver cancer	0.000288	0.0115	CcSEcCtD
Pitavastatin—Pain in extremity—Epirubicin—liver cancer	0.000287	0.0114	CcSEcCtD
Pitavastatin—Hypersensitivity—Sorafenib—liver cancer	0.000281	0.0112	CcSEcCtD
Pitavastatin—Asthenia—Sorafenib—liver cancer	0.000274	0.0109	CcSEcCtD
Pitavastatin—Pruritus—Sorafenib—liver cancer	0.00027	0.0108	CcSEcCtD
Pitavastatin—Pain in extremity—Doxorubicin—liver cancer	0.000266	0.0106	CcSEcCtD
Pitavastatin—Diarrhoea—Sorafenib—liver cancer	0.000261	0.0104	CcSEcCtD
Pitavastatin—Nasopharyngitis—Epirubicin—liver cancer	0.000257	0.0102	CcSEcCtD
Pitavastatin—Dizziness—Sorafenib—liver cancer	0.000252	0.0101	CcSEcCtD
Pitavastatin—Influenza—Epirubicin—liver cancer	0.000248	0.00989	CcSEcCtD
Pitavastatin—Rash—Sorafenib—liver cancer	0.000241	0.0096	CcSEcCtD
Pitavastatin—Dermatitis—Sorafenib—liver cancer	0.00024	0.00959	CcSEcCtD
Pitavastatin—Headache—Sorafenib—liver cancer	0.000239	0.00954	CcSEcCtD
Pitavastatin—Nasopharyngitis—Doxorubicin—liver cancer	0.000237	0.00947	CcSEcCtD
Pitavastatin—Influenza—Doxorubicin—liver cancer	0.000229	0.00915	CcSEcCtD
Pitavastatin—Nausea—Sorafenib—liver cancer	0.000227	0.00904	CcSEcCtD
Pitavastatin—Jaundice—Epirubicin—liver cancer	0.000216	0.0086	CcSEcCtD
Pitavastatin—Jaundice—Doxorubicin—liver cancer	0.000199	0.00796	CcSEcCtD
Pitavastatin—Hepatitis—Epirubicin—liver cancer	0.000199	0.00792	CcSEcCtD
Pitavastatin—Hypoaesthesia—Epirubicin—liver cancer	0.000198	0.00788	CcSEcCtD
Pitavastatin—Hepatitis—Doxorubicin—liver cancer	0.000184	0.00733	CcSEcCtD
Pitavastatin—Hypoaesthesia—Doxorubicin—liver cancer	0.000183	0.00729	CcSEcCtD
Pitavastatin—ABCB1—liver—liver cancer	0.000182	0.00126	CbGeAlD
Pitavastatin—Back pain—Epirubicin—liver cancer	0.000167	0.00667	CcSEcCtD
Pitavastatin—Muscle spasms—Epirubicin—liver cancer	0.000166	0.00663	CcSEcCtD
Pitavastatin—Ill-defined disorder—Epirubicin—liver cancer	0.00016	0.0064	CcSEcCtD
Pitavastatin—Malaise—Epirubicin—liver cancer	0.000156	0.00622	CcSEcCtD
Pitavastatin—Back pain—Doxorubicin—liver cancer	0.000155	0.00617	CcSEcCtD
Pitavastatin—Muscle spasms—Doxorubicin—liver cancer	0.000154	0.00613	CcSEcCtD
Pitavastatin—Ill-defined disorder—Doxorubicin—liver cancer	0.000148	0.00592	CcSEcCtD
Pitavastatin—Arthralgia—Epirubicin—liver cancer	0.000147	0.00587	CcSEcCtD
Pitavastatin—Myalgia—Epirubicin—liver cancer	0.000147	0.00587	CcSEcCtD
Pitavastatin—Discomfort—Epirubicin—liver cancer	0.000145	0.0058	CcSEcCtD
Pitavastatin—Malaise—Doxorubicin—liver cancer	0.000144	0.00575	CcSEcCtD
Pitavastatin—Confusional state—Epirubicin—liver cancer	0.000142	0.00567	CcSEcCtD
Pitavastatin—Myalgia—Doxorubicin—liver cancer	0.000136	0.00543	CcSEcCtD
Pitavastatin—Arthralgia—Doxorubicin—liver cancer	0.000136	0.00543	CcSEcCtD
Pitavastatin—Discomfort—Doxorubicin—liver cancer	0.000135	0.00537	CcSEcCtD
Pitavastatin—Confusional state—Doxorubicin—liver cancer	0.000132	0.00525	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000129	0.00513	CcSEcCtD
Pitavastatin—Insomnia—Epirubicin—liver cancer	0.000128	0.00509	CcSEcCtD
Pitavastatin—Dyspepsia—Epirubicin—liver cancer	0.000124	0.00495	CcSEcCtD
Pitavastatin—Fatigue—Epirubicin—liver cancer	0.000122	0.00485	CcSEcCtD
Pitavastatin—Constipation—Epirubicin—liver cancer	0.000121	0.00481	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000119	0.00474	CcSEcCtD
Pitavastatin—Insomnia—Doxorubicin—liver cancer	0.000118	0.00471	CcSEcCtD
Pitavastatin—Feeling abnormal—Epirubicin—liver cancer	0.000116	0.00464	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Epirubicin—liver cancer	0.000115	0.0046	CcSEcCtD
Pitavastatin—Dyspepsia—Doxorubicin—liver cancer	0.000115	0.00458	CcSEcCtD
Pitavastatin—Fatigue—Doxorubicin—liver cancer	0.000113	0.00449	CcSEcCtD
Pitavastatin—Urticaria—Epirubicin—liver cancer	0.000112	0.00447	CcSEcCtD
Pitavastatin—Constipation—Doxorubicin—liver cancer	0.000112	0.00445	CcSEcCtD
Pitavastatin—Abdominal pain—Epirubicin—liver cancer	0.000111	0.00445	CcSEcCtD
Pitavastatin—Feeling abnormal—Doxorubicin—liver cancer	0.000108	0.00429	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000107	0.00426	CcSEcCtD
Pitavastatin—Hypersensitivity—Epirubicin—liver cancer	0.000104	0.00415	CcSEcCtD
Pitavastatin—Urticaria—Doxorubicin—liver cancer	0.000104	0.00414	CcSEcCtD
Pitavastatin—Abdominal pain—Doxorubicin—liver cancer	0.000103	0.00412	CcSEcCtD
Pitavastatin—Asthenia—Epirubicin—liver cancer	0.000101	0.00404	CcSEcCtD
Pitavastatin—Pruritus—Epirubicin—liver cancer	9.98e-05	0.00398	CcSEcCtD
Pitavastatin—Diarrhoea—Epirubicin—liver cancer	9.65e-05	0.00385	CcSEcCtD
Pitavastatin—Hypersensitivity—Doxorubicin—liver cancer	9.62e-05	0.00384	CcSEcCtD
Pitavastatin—Asthenia—Doxorubicin—liver cancer	9.36e-05	0.00374	CcSEcCtD
Pitavastatin—Dizziness—Epirubicin—liver cancer	9.33e-05	0.00372	CcSEcCtD
Pitavastatin—Pruritus—Doxorubicin—liver cancer	9.23e-05	0.00368	CcSEcCtD
Pitavastatin—Diarrhoea—Doxorubicin—liver cancer	8.93e-05	0.00356	CcSEcCtD
Pitavastatin—Rash—Epirubicin—liver cancer	8.89e-05	0.00355	CcSEcCtD
Pitavastatin—Dermatitis—Epirubicin—liver cancer	8.88e-05	0.00354	CcSEcCtD
Pitavastatin—Headache—Epirubicin—liver cancer	8.84e-05	0.00352	CcSEcCtD
Pitavastatin—Dizziness—Doxorubicin—liver cancer	8.63e-05	0.00344	CcSEcCtD
Pitavastatin—Nausea—Epirubicin—liver cancer	8.38e-05	0.00334	CcSEcCtD
Pitavastatin—Rash—Doxorubicin—liver cancer	8.23e-05	0.00328	CcSEcCtD
Pitavastatin—Dermatitis—Doxorubicin—liver cancer	8.22e-05	0.00328	CcSEcCtD
Pitavastatin—Headache—Doxorubicin—liver cancer	8.18e-05	0.00326	CcSEcCtD
Pitavastatin—Nausea—Doxorubicin—liver cancer	7.75e-05	0.00309	CcSEcCtD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—RAF1—liver cancer	1.69e-05	0.000119	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	1.68e-05	0.000118	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP2E1—liver cancer	1.68e-05	0.000118	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—MTHFR—liver cancer	1.68e-05	0.000118	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	1.67e-05	0.000117	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GOT2—liver cancer	1.66e-05	0.000117	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	1.65e-05	0.000116	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PPARA—liver cancer	1.64e-05	0.000116	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.63e-05	0.000115	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	1.62e-05	0.000114	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP1A1—liver cancer	1.62e-05	0.000114	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.62e-05	0.000114	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CD—liver cancer	1.61e-05	0.000113	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GLUL—liver cancer	1.6e-05	0.000113	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CPT1B—liver cancer	1.6e-05	0.000113	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTA4—liver cancer	1.59e-05	0.000112	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ALB—liver cancer	1.59e-05	0.000112	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTA4—liver cancer	1.59e-05	0.000112	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	1.59e-05	0.000112	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYCS—liver cancer	1.57e-05	0.000111	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.56e-05	0.00011	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP2E1—liver cancer	1.56e-05	0.00011	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTA2—liver cancer	1.55e-05	0.000109	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.55e-05	0.000109	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	1.55e-05	0.000109	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTA2—liver cancer	1.55e-05	0.000109	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NR1H4—liver cancer	1.55e-05	0.000109	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GGT1—liver cancer	1.54e-05	0.000109	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GOT1—liver cancer	1.54e-05	0.000109	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	1.52e-05	0.000107	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTA3—liver cancer	1.52e-05	0.000107	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—MTHFR—liver cancer	1.51e-05	0.000107	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTA1—liver cancer	1.5e-05	0.000106	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GLUL—liver cancer	1.5e-05	0.000105	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CPT1B—liver cancer	1.5e-05	0.000105	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CG—liver cancer	1.49e-05	0.000105	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTA1—liver cancer	1.49e-05	0.000105	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PPARA—liver cancer	1.48e-05	0.000104	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NAT2—liver cancer	1.48e-05	0.000104	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.48e-05	0.000104	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NAT2—liver cancer	1.47e-05	0.000104	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	1.47e-05	0.000103	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	1.46e-05	0.000103	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYCS—liver cancer	1.46e-05	0.000103	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NR1H4—liver cancer	1.44e-05	0.000102	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PPARG—liver cancer	1.44e-05	0.000102	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK14—liver cancer	1.44e-05	0.000101	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GGT1—liver cancer	1.43e-05	0.000101	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GOT1—liver cancer	1.43e-05	0.000101	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.43e-05	0.0001	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALDOB—liver cancer	1.42e-05	0.0001	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	1.42e-05	0.0001	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTA3—liver cancer	1.42e-05	9.99e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.42e-05	9.98e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ALDOB—liver cancer	1.41e-05	9.95e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CG—liver cancer	1.41e-05	9.92e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CB—liver cancer	1.4e-05	9.89e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	1.4e-05	9.87e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	1.4e-05	9.85e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—F2—liver cancer	1.39e-05	9.81e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTA4—liver cancer	1.39e-05	9.78e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTP1—liver cancer	1.39e-05	9.77e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—HMOX1—liver cancer	1.37e-05	9.63e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PPARG—liver cancer	1.36e-05	9.57e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CRABP1—liver cancer	1.36e-05	9.55e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTA2—liver cancer	1.35e-05	9.54e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CRABP1—liver cancer	1.35e-05	9.5e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	1.35e-05	9.49e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CG—liver cancer	1.33e-05	9.39e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CD—liver cancer	1.31e-05	9.25e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTA1—liver cancer	1.31e-05	9.2e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	1.31e-05	9.19e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTA4—liver cancer	1.3e-05	9.14e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ALB—liver cancer	1.3e-05	9.13e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	1.3e-05	9.12e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NAT2—liver cancer	1.29e-05	9.1e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTP1—liver cancer	1.28e-05	9.04e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTM1—liver cancer	1.27e-05	8.97e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CG—liver cancer	1.27e-05	8.95e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.27e-05	8.93e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—HMOX1—liver cancer	1.27e-05	8.92e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTA2—liver cancer	1.26e-05	8.91e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALDOB—liver cancer	1.24e-05	8.72e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CD—liver cancer	1.24e-05	8.72e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PPARG—liver cancer	1.23e-05	8.64e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALB—liver cancer	1.22e-05	8.61e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.22e-05	8.6e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTA1—liver cancer	1.22e-05	8.59e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.21e-05	8.55e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	1.21e-05	8.51e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP1A1—liver cancer	1.21e-05	8.51e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NAT2—liver cancer	1.21e-05	8.5e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.19e-05	8.38e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HPGDS—liver cancer	1.19e-05	8.35e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CRABP1—liver cancer	1.18e-05	8.32e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.18e-05	8.32e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTM1—liver cancer	1.18e-05	8.31e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HPGDS—liver cancer	1.18e-05	8.3e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.18e-05	8.3e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CD—liver cancer	1.17e-05	8.26e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.17e-05	8.25e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.16e-05	8.17e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SERPINE1—liver cancer	1.16e-05	8.17e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALDOB—liver cancer	1.16e-05	8.15e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.15e-05	8.11e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CB—liver cancer	1.15e-05	8.06e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—MTHFR—liver cancer	1.13e-05	7.93e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP1A1—liver cancer	1.12e-05	7.88e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CD—liver cancer	1.12e-05	7.87e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARA—liver cancer	1.1e-05	7.78e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CRABP1—liver cancer	1.1e-05	7.77e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—liver cancer	1.1e-05	7.77e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CB—liver cancer	1.08e-05	7.6e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.07e-05	7.56e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.07e-05	7.52e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.06e-05	7.46e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PSMA4—liver cancer	1.06e-05	7.44e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PSMD10—liver cancer	1.06e-05	7.44e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CA—liver cancer	1.05e-05	7.4e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PSMA4—liver cancer	1.05e-05	7.4e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PSMD10—liver cancer	1.05e-05	7.4e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—RAF1—liver cancer	1.05e-05	7.37e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—MTHFR—liver cancer	1.04e-05	7.34e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HPGDS—liver cancer	1.03e-05	7.27e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GOT2—liver cancer	1.03e-05	7.24e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARA—liver cancer	1.02e-05	7.2e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GOT2—liver cancer	1.02e-05	7.2e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CB—liver cancer	1.02e-05	7.2e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.94e-06	7e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.93e-06	6.99e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	9.87e-06	6.95e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CB—liver cancer	9.74e-06	6.86e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	9.72e-06	6.85e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP2E1—liver cancer	9.66e-06	6.8e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HPGDS—liver cancer	9.65e-06	6.79e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP2E1—liver cancer	9.61e-06	6.77e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.59e-06	6.75e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CG—liver cancer	9.46e-06	6.66e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2—liver cancer	9.38e-06	6.61e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.36e-06	6.59e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.3e-06	6.55e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PSMD10—liver cancer	9.2e-06	6.48e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PSMA4—liver cancer	9.2e-06	6.48e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARG—liver cancer	9.13e-06	6.43e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	9.06e-06	6.38e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYCS—liver cancer	9.04e-06	6.37e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYCS—liver cancer	8.99e-06	6.33e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GOT2—liver cancer	8.95e-06	6.31e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GGT1—liver cancer	8.87e-06	6.25e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GOT1—liver cancer	8.87e-06	6.25e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GGT1—liver cancer	8.82e-06	6.21e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GOT1—liver cancer	8.82e-06	6.21e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	8.78e-06	6.18e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CG—liver cancer	8.76e-06	6.17e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.74e-06	6.15e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.62e-06	6.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PSMA4—liver cancer	8.6e-06	6.06e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PSMD10—liver cancer	8.6e-06	6.06e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—liver cancer	8.58e-06	6.04e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CA—liver cancer	8.56e-06	6.03e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARG—liver cancer	8.46e-06	5.96e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP2E1—liver cancer	8.42e-06	5.93e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GOT2—liver cancer	8.36e-06	5.89e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CD—liver cancer	8.32e-06	5.86e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—liver cancer	8.21e-06	5.78e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—liver cancer	7.98e-06	5.62e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTP1—liver cancer	7.97e-06	5.61e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	7.94e-06	5.59e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTP1—liver cancer	7.92e-06	5.58e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYCS—liver cancer	7.88e-06	5.55e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP2E1—liver cancer	7.86e-06	5.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HMOX1—liver cancer	7.86e-06	5.53e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HMOX1—liver cancer	7.81e-06	5.5e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GGT1—liver cancer	7.73e-06	5.44e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GOT1—liver cancer	7.73e-06	5.44e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CD—liver cancer	7.7e-06	5.42e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.61e-06	5.36e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—liver cancer	7.6e-06	5.35e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYCS—liver cancer	7.36e-06	5.18e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTM1—liver cancer	7.32e-06	5.16e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB1—liver cancer	7.32e-06	5.15e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTM1—liver cancer	7.28e-06	5.13e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CB—liver cancer	7.25e-06	5.11e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GGT1—liver cancer	7.22e-06	5.08e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GOT1—liver cancer	7.22e-06	5.08e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—liver cancer	7e-06	4.93e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CA—liver cancer	6.98e-06	4.92e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTP1—liver cancer	6.94e-06	4.89e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP1A1—liver cancer	6.94e-06	4.89e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP1A1—liver cancer	6.9e-06	4.86e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HMOX1—liver cancer	6.85e-06	4.82e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KRAS—liver cancer	6.78e-06	4.77e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CB—liver cancer	6.71e-06	4.73e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CA—liver cancer	6.58e-06	4.63e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTP1—liver cancer	6.49e-06	4.57e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—MTHFR—liver cancer	6.47e-06	4.56e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—MTHFR—liver cancer	6.44e-06	4.53e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HMOX1—liver cancer	6.4e-06	4.5e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTM1—liver cancer	6.38e-06	4.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARA—liver cancer	6.35e-06	4.47e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARA—liver cancer	6.31e-06	4.45e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CA—liver cancer	6.23e-06	4.39e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP1A1—liver cancer	6.05e-06	4.26e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—liver cancer	6.03e-06	4.24e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTM1—liver cancer	5.96e-06	4.2e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CA—liver cancer	5.94e-06	4.18e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HRAS—liver cancer	5.76e-06	4.06e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.7e-06	4.02e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—liver cancer	5.7e-06	4.02e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.67e-06	3.99e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP1A1—liver cancer	5.65e-06	3.98e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MTHFR—liver cancer	5.64e-06	3.97e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARA—liver cancer	5.53e-06	3.9e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CG—liver cancer	5.44e-06	3.83e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CG—liver cancer	5.41e-06	3.81e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—liver cancer	5.37e-06	3.78e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MTHFR—liver cancer	5.27e-06	3.71e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARG—liver cancer	5.25e-06	3.7e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARG—liver cancer	5.22e-06	3.67e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARA—liver cancer	5.17e-06	3.64e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—liver cancer	5.09e-06	3.58e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—liver cancer	4.85e-06	3.41e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CD—liver cancer	4.78e-06	3.37e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CD—liver cancer	4.75e-06	3.35e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CG—liver cancer	4.74e-06	3.34e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—liver cancer	4.72e-06	3.32e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.64e-06	3.27e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARG—liver cancer	4.57e-06	3.22e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CG—liver cancer	4.43e-06	3.12e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CA—liver cancer	4.42e-06	3.11e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARG—liver cancer	4.27e-06	3.01e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CB—liver cancer	4.17e-06	2.93e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CD—liver cancer	4.16e-06	2.93e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CB—liver cancer	4.14e-06	2.92e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—liver cancer	4.11e-06	2.9e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CA—liver cancer	4.09e-06	2.88e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CD—liver cancer	3.89e-06	2.74e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—liver cancer	3.84e-06	2.7e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CB—liver cancer	3.63e-06	2.56e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—liver cancer	3.61e-06	2.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CB—liver cancer	3.39e-06	2.39e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—liver cancer	3.34e-06	2.35e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CA—liver cancer	2.54e-06	1.79e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CA—liver cancer	2.53e-06	1.78e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CA—liver cancer	2.21e-06	1.56e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—liver cancer	2.07e-06	1.46e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CA—liver cancer	2.07e-06	1.46e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—liver cancer	2.06e-06	1.45e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—liver cancer	1.81e-06	1.27e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—liver cancer	1.69e-06	1.19e-05	CbGpPWpGaD
